CONTROLLED SUBSTANCES ACT

Bills and resolutions

Anabolic Steroid Control Act: technical corrections (see S. 893), S4184 [25AP]

Drugs: adjust penalties for powder cocaine and crack cocaine offenses (see H.R. 48), H73 [4JA] (see H.R. 1501), H1844 [6AP]

———allow for medicinal use of marijuana in accordance with State laws (see H.R. 2087), H2976 [4MY]

———amend relative to distribution of pseudoephedrine (see H.R. 1056), H940 [2MR]

———amend relative to methamphetamine (see H.R. 3756), H7861 [13SE]

———amend relative to regulation of ephedrine alkaloids (see H.R. 1083), H981 [3MR] (see H.R. 1378), H1691 [17MR]

———eliminate certain mandatory minimum penalties for crack cocaine offenses (see H.R. 2456), H3555 [18MY]

———eliminate safe-harbor exception for certain packaged pseudoephedrine products used in manufacturing methamphetamine (see H.R. 1446), H1694 [17MR]

———lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices (see S. 45), S143 [24JA] (see H.R. 869), H718 [16FE]

———prohibit third-party Internet sales sites from posting offers to sell controlled substances (see H.R. 3608), H7561 [28JY]

———provide an affirmative defense for medical use of marijuana in Federal criminal trials occuring in States with medical marijuana use laws (see H.R. 4272), H10144 [9NO]

———provide an increased penalty for endangering a child while illegally manufacturing a controlled substance (see H.R. 1616), H1969 [13AP]

———provide civil liability for illegal manufacturers and distributors of controlled substances for the harm caused by the use of those controlled substances (see H.R. 2348), H3261 [12MY]

———provide increased penalties for methamphetamine traffickers (see H.R. 3755), H7860 [13SE]

———provide penalties for open air drug markets (see H.R. 1758), H2469 [21AP]

———transfer ephedrine, pseudoephedrine, and phenylpropanolamine to schedule V of the schedules of controlled substances (see H.R. 3568), H7559 [28JY] (see H.R. 3955), H8642 [29SE]

Law enforcement: exclude industrial hemp from the definition of marijuana (see H.R. 3037), H4984 [22JN]

———protect vulnerable persons from drug trafficking (see H.R. 1528), H1845 [6AP]

———treat drug offenses involving crystal methamphetamine similarly to drug offenses involving crack cocaine (see S. 1361), S7820 [30JN]

Remarks in House

Drugs: eliminate safe-harbor exception for certain packaged pseudoephedrine products used in manufacturing methamphetamine (H.R. 1446), H2784 [3MY], H3681 [19MY]

———lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices (S. 45), H6679-H6681 [27JY]

———provide an increased penalty for endangering a child while illegally manufacturing a controlled substance (H.R. 1616), H4194 [8JN]

———transfer ephedrine, pseudoephedrine, and phenylpropanolamine to schedule V of the schedules of controlled substances (H.R. 3955), H10135 [9NO]

Law enforcement: exclude industrial hemp from the definition of marijuana (H.R. 3037), E1313 [22JN]

Remarks in Senate

Anabolic Steroid Control Act: technical corrections (S. 893), S4162 [25AP]

Drugs: lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices (S. 45), S231 [24JA], S829 [1FE], S8501 [19JY]

Reports filed

Lift the Patient Limitation on Prescribing Drug Addiction Treatments by Medical Practitioners in Group Practices: Committee on Energy and Commerce (House) (H.R. 869) (H. Rept. 109-116), H4354 [9JN]

———Committee on the Judiciary (House) (H.R. 869) (H. Rept. 109-116), H5637 [11JY]

Texts of

S. 45, lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices, S232 [24JA], S8501 [19JY], H6679 [27JY]

S. 893, Anabolic Steroid Control Act technical corrections, S4162 [25AP]